Saisamarth International
Sectors as filed: Diversified Chemicals
The website is as filed on the register. We have not checked that it resolves. Something wrong with this record?
Six things we look for on every record: DPIIT recognition, a CIN, a website, a description, a logo and a funding signal. Not held here: DPIIT recognised, CIN on file and Funding signal.
Where this is
District
Aurangabad
Maharashtra
Startup India records the district. We do not have a street address for this company, and we will not invent one.
No point is drawn, because we do not have one.
Geocode confidence: medium
See all Aurangabad records on the map How we placed this record
What this record amounts to
Saisamarth International is a Startup India record we can place no finer than Aurangabad district, which holds 1,971 records in this snapshot. It is filed under Chemicals, which 4,328 records carry nationally. It carries no funding signal of any class, which is true of 1,737 of the 1,971 records in Aurangabad.
Every figure above is counted from the 2026-08 snapshot and is the same number the page it links to prints.
In their own words
Rational Now a day’s rate of human health diseases are increasing rapidly, medical treatment with the help of drugs/medicines is a common practices in which, medicines/drugs plays the important role in recover the health & control the diseases. Pharmaceuticals industries required raw material in the form of synthetic chemicals, bulk drugs, intermediates to prepare final products as a medicine. Bulk drugs interemdiates are the active raw materials used in drug that are useful as therapeutic agents. Therefore, proposed manufacturing of various Bulk Drugs & Intermediates has importance. Many pharma companies enjoy success largely because their major operations are based in Maharashtra. The government support received by the industry has been substantial and the presence of a pragmatic and stable state government has been one of the main reasons the state has managed to remain a principal destination for all pharma companies whether Indian or MNC. Maharashtra has been a hub for the pharma industry, both in terms of manufacturing as well as supply of materials. Aurangabad industrial belt occupies 40% of chemical producing industries for pharma and other industries. In view of future market demand it is best opportunity to set up a business in Aurangabad which may lead to employment generation to local youth and economical upliftment of Paithan region. Market and its analysis Rapid industrialization is very essential for improving the country’s economy & becoming self-reliant. India has embarked upon extensive industrial development in the last few years and with the process of economic reforms and liberalization, it is expected to get accelerated further. It needs to be over emphasized that allopathic life saving drug technology plays a crucial role in daily life. India is emerging as Global Powerhouse in API. It is increasingly being recognized as reliable source of quality API at affordable prices. API segment in India is very competitive sector. Presently price realization has improved, and expected to stabilize in future with rapid increase in growth of Pharmaceutical industry. Antituberculosis, Antidepressants, hypertensive, anti-ulcerative, vascular dysfunctions, etc. present a huge business opportunity even for small and medium players. The key factors driving pharmaceutical growth worldwide have been population growth, increased longevity or people, changing lifestyles, increasing wealth, and new applications for existing products. India is driving the market growth through their cost advantages and has emerged as manufacturing hubs for the APIs. With government supportand manufacturing standards in India, the generic as well as innovator APIs market in Asia-Pacific is expected to grow steadily in the coming years. As per central government policy, more emphasis is given on opportunities for Indian API manufacturer. Near about 80 % of API is imported from China, hence there is ample of scope for the API manufacturing units to provide cost effective medicines. Demand-Supply Gap The Indian pharmaceutical industry is the world's second-largest by volume and is likely to lead the manufacturing sector of India. Several Government and private sector projects with huge amount of investments have been initiated but could not attend the speed of development for the need of good quality material. Over the last decade, there has been a sizeable growth in Pharmaceutical sector both in small, medium and large scale units. This has given rise to many small and medium scale units to manufacture pharmaceutical intermediate. The ever growing requirements of India, due to higher population and various diseases indicated the need for the growth of this industry. Thus there is a gap in demand and supply. Our efforts of generating products, by-products, downstream products and recycling - reprocessing are indeed needed. With multinational pharmaceutical companies enhancing their presence in India, the long-term prospects of the pharmaceutical industry seem fairly bright. Indian agro sector demand is increasing to improve productivity and to deal with attack of various types of pests etc. The intermediates proposed will substitute imports. The food industry demand for preservative is increasing as multinational companies are shifting manufacturing base in India. But the impact of some factors on the industry's growth remains to be seen. The fate of industrialization depends on the proper and effective conjugation of large and medium/small scale industries each supporting each other in their requirement to bridge the gap between demand and supply. In order to be competitive in the global market this synergy between large & medium/small scale industries is a prerogative. Therefore considering the above, large companies do require the help of small units to support them by giving them quality products at lesser price. Introduction The project is being promoted by M/s Saisamarth International. (SSI), with a v
Written by the company on its public Startup India profile. Not verified by us.
What the record says
- Registered on Startup India
- 2024
- Self-declared stage
- Prototype
- Industry
- Chemicals
- District
- Aurangabad
- State
- Maharashtra
The neighbourhood
This record carries no locality line, so the district is the finest ring we can place it in.
What we do not know
- no CIN on file, so no company-registry record is linked
- no incorporation date
- no funding signal of any kind
- no address beyond the district
We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.
Is this your company?
Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.
How we built this record Where the data comes from How you may reuse it
Keep looking
One record is one row. Aurangabad has 1,971.
See Aurangabad